PPAR-γ regulates pharmacological but not physiological or pathological osteoclast formation

Loss of Mitochondrial Pyruvate Carrier 2 in the Liver Leads to Defects in Gluconeogenesis and Compensation via Pyruvate-Alanine Cycling

(2015) Kyle S. McCommis et al.   Cell Metabolism

An Insulin-Sensitizing Thiazolidinedione, Which Minimally Activates PPARγ, Does Not Cause Bone Loss

(2015) Tomohiro Fukunaga et al.   JOURNAL OF BONE AND MINERAL RESEARCH

ASXL2 Regulates Glucose, Lipid, and Skeletal Homeostasis

(2015) Takashi Izawa et al.   Cell Reports

Insulin Resistance and Metabolic Derangements in Obese Mice Are Ameliorated by a Novel Peroxisome Proliferator-activated Receptor γ-sparing Thiazolidinedione

(2012) Zhouji Chen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis

(2012) Kazuhiro Maeda et al.   NATURE MEDICINE

Osteoclast Progenitors Reside in the Peroxisome Proliferator-Activated Receptor  -Expressing Bone Marrow Cell Population

(2011) W. Wei et al.   MOLECULAR AND CELLULAR BIOLOGY

Thiazolidinedione-induced skeletal fragility - mechanisms and implications

(2008) Andrew Grey   DIABETES OBESITY & METABOLISM